Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …

1. Background Liver transplantation significantly improves the survival and quality of life of
patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common
cause of liver disease and liver cancer. HBV, a member of the Hepadnaviridae family, is a …

The hepatitis B virus (HBV), discovered in 1966, infects more than 350 million people
worldwide. 1 Hepatitis B is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular …

Background The effectiveness of antiviral therapy in preventing disease progression in
patients with chronic hepatitis B and advanced fibrosis or cirrhosis is unknown. Methods …

Background & Aims: Cirrhosis develops as a result of hepatic inflammation and subsequent
fibrosis in chronic hepatitis B infection. We report on the relationship between hepatitis B …

Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are
identified: an immune tolerant phase with high HBV DNA and normal alanine …

Background: There are numerous studies concerning the natural history and prognostic
factors in cirrhosis, the results of which are useful in selecting liver transplant candidates …

Background and Methods In preliminary trials, lamivudine, an oral nucleoside analogue, has
shown promise for the treatment of chronic hepatitis B. We conducted a one-year, double …